Lorcaserin for Weight Loss: Insights Into US Food and Drug Administration Approval

被引：10
|
作者：
Miller, Larry E. [1 ]
机构：
[1] Miller Sci Consulting Inc, Arden, NC 28704 USA
来源：
JOURNAL OF THE ACADEMY OF NUTRITION AND DIETETICS | 2013年 / 113卷 / 01期
关键词：
Drug; Lorcaserin; Obesity; Overweight; Weight loss; OBESITY; TRIAL; OVERWEIGHT; AGONIST; ADULTS; RISK;
D O I：
10.1016/j.jand.2012.08.028
中图分类号：
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号：
100403 ;
摘要：
[No abstract available]
引用
收藏
页码：25 / 30
页数：6
相关论文
共 50 条
  • [41] US Food and Drug Administration drug approval summaries: Imatinib mesylate, mesna tablets, and zoledronic acid
    Cohen, MH
    Dagher, R
    Griebel, DJ
    Ibrahim, A
    Martin, A
    Scher, NS
    Sokol, GH
    Williams, GA
    Pazdur, R
    ONCOLOGIST, 2002, 7 (05): : 393 - 400
  • [42] US food and drug administration
    Goodman, Jesse
    ONCOLOGY-NEW YORK, 2006, 20 (08): : 946 - 946
  • [43] US Food and Drug Administration
    Blumenthal, G.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S37 - S37
  • [44] Food and Drug Administration Drug Approval Process A History and Overview
    Williams, Christopher Ty
    NURSING CLINICS OF NORTH AMERICA, 2016, 51 (01) : 1 - +
  • [45] Has the Food and Drug Administration Changed the Drug Approval Process?
    Somberg, John C.
    AMERICAN JOURNAL OF THERAPEUTICS, 2011, 18 (03) : 179 - 179
  • [46] Exposure to US Cancer Drugs With Lack of Confirmed Benefit After US Food and Drug Administration Accelerated Approval
    Parikh, Ravi B. B.
    Hubbard, Rebecca A. A.
    Wang, Erkuan
    Royce, Trevor J. J.
    Cohen, Aaron B. B.
    Clark, Amy S. S.
    Mamtani, Ronac
    JAMA ONCOLOGY, 2023, 9 (04) : 567 - 569
  • [47] US food and drug administration drug approval summary: Conversion of imatinib mesylate (ST1571; Gleevec) tablets from accelerated approval to full approval
    Cohen, MH
    Johnson, JR
    Pazdur, R
    CLINICAL CANCER RESEARCH, 2005, 11 (01) : 12 - 19
  • [48] US Food and Drug Administration approval of generic versions of complex biologics: implications for the practicing physician using low molecular weight heparins
    Cohen, Marc
    Jeske, Walter P.
    Nicolau, Jose C.
    Montalescot, Gilles
    Fareed, Jawed
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2012, 33 (03) : 230 - 238
  • [49] US Food and Drug Administration approval of generic versions of complex biologics: implications for the practicing physician using low molecular weight heparins
    Marc Cohen
    Walter P. Jeske
    Jose C. Nicolau
    Gilles Montalescot
    Jawed Fareed
    Journal of Thrombosis and Thrombolysis, 2012, 33 : 230 - 238
  • [50] Eyes on the Prize: Decoding the Ophthalmic Product Regulations and Intricacies of the US Food and Drug Administration Approval
    Hirani, Khemraj
    Bansinath, Mylarrao
    Mittal, Rahul
    Lemos, Joana R. N.
    Adis, Emily
    Poojari, Priyanka
    Igoe, Jane Margaret
    Soares, Marcio R.
    Bhattacharya, Sanjoy
    Weiss, Roy E.
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2023, 39 (08) : 572 - 582
12345